No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs79269946 |
chr3:120274220-120274221 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs560281402 |
chr3:120274262-120274263 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs182949499 |
chr3:120274263-120274264 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs546119138 |
chr3:120274264-120274265 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs147460391 |
chr3:120274277-120274278 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs530573106 |
chr3:120274298-120274299 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs550259412 |
chr3:120274327-120274328 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs567362804 |
chr3:120274432-120274433 |
Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs139822922 |
chr3:120274560-120274561 |
Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs546837937 |
chr3:120274604-120274605 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs10511399 |
chr3:120274668-120274669 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
12 |
rs538821367 |
chr3:120274670-120274671 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs377629253 |
chr3:120274688-120274689 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs71327235 |
chr3:120274689-120274690 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs35446232 |
chr3:120274692-120274693 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs71327236 |
chr3:120274698-120274699 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs558934901 |
chr3:120274739-120274740 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs372847463 |
chr3:120274748-120274749 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs569170905 |
chr3:120274752-120274753 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs542058028 |
chr3:120274753-120274754 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs538243696 |
chr3:120274838-120274839 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs554628936 |
chr3:120274871-120274872 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs144600183 |
chr3:120274946-120274947 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs540343496 |
chr3:120274967-120274968 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs553830838 |
chr3:120274997-120274998 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs187579883 |
chr3:120275012-120275013 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs550850731 |
chr3:120275131-120275132 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs571036156 |
chr3:120275132-120275133 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs148464654 |
chr3:120275161-120275162 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs142627930 |
chr3:120275205-120275206 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs111232351 |
chr3:120275206-120275207 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs560693138 |
chr3:120275212-120275213 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs529669938 |
chr3:120275280-120275281 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs139869757 |
chr3:120275283-120275284 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs375070663 |
chr3:120275302-120275303 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs369575406 |
chr3:120275353-120275354 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs546752116 |
chr3:120275416-120275417 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs560280313 |
chr3:120275489-120275490 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs143220638 |
chr3:120275594-120275595 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs146678609 |
chr3:120275621-120275622 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs140229051 |
chr3:120275625-120275626 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs144541193 |
chr3:120275652-120275653 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs565658845 |
chr3:120275702-120275703 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs145394339 |
chr3:120275748-120275749 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs113146365 |
chr3:120275796-120275797 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs63597260 |
chr3:120275797-120275798 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs377636340 |
chr3:120275798-120275799 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs369695926 |
chr3:120275799-120275800 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs374337184 |
chr3:120275800-120275801 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs377743990 |
chr3:120275801-120275802 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|